8 months ago1 min0 Biogen scraps controversial Alzheimer’s drug Aduhelm Tweet Biogen takes $60 million quarterly hit in opting to no longer study or sell the drug that never met expectations. Tweet Post navigation January 31, 2024IND vs ENG: Harbhajan Singh warns Rohit Sharma’s Team India ahead of the Vizag TestJanuary 31, 2024Ophthalmologist shares tips on preventing eye problems and protecting your sight